Literature DB >> 3106578

Focal epileptic activity following intravenous contrast material injection in patients with metastatic brain disease.

E Avrahami, J Weiss-Peretz, D F Cohn.   

Abstract

Four patients with metastatic brain disease were referred for computed tomographic (CT) examination with contrast material injection. Within 2 to 4 minutes after the intravenous administration of water soluble contrast agent, focal epileptic activity occurred. The seizures became generalised in two of the patients who later died following status epilepticus. In the other two patients the focal seizures correlated with the localisation of the metastatic mass lesions. None of the patients had a previous history of epilepsy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106578      PMCID: PMC1031496          DOI: 10.1136/jnnp.50.2.221

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  10 in total

1.  X-ray contrast media for cardiovascular angiography.

Authors:  J O HOPPE; S ARCHER
Journal:  Angiology       Date:  1960-06       Impact factor: 3.619

2.  Cerebrovascular permeability of a water-soluble contrast material, Hypaque (sodium diatrizoate). Experimental study in dogs.

Authors:  K F Lampe; G James; M Erbesfeld; T J Mende; M Viamonte
Journal:  Invest Radiol       Date:  1970 Mar-Apr       Impact factor: 6.016

3.  Adverse reactions to contrast agents. Scope of problem.

Authors:  G Ansell
Journal:  Invest Radiol       Date:  1970 Nov-Dec       Impact factor: 6.016

4.  Focal seizure disorder complicating iodophendylate myelography.

Authors:  M K Greenberg; S C Vance
Journal:  Lancet       Date:  1980-02-09       Impact factor: 79.321

Review 5.  Contrast media reactions: data analysis and hypothesis.

Authors:  A F Lalli
Journal:  Radiology       Date:  1980-01       Impact factor: 11.105

6.  Adverse reactions to contrast media: a report from the Committee on Safety of Contrast Media of the International Society of Radiology.

Authors:  W H Shehadi; G Toniolo
Journal:  Radiology       Date:  1980-11       Impact factor: 11.105

7.  Contrast agent-induced emesis.

Authors:  A R Manhire; P Dawson; R Dennet
Journal:  Clin Radiol       Date:  1984-09       Impact factor: 2.350

8.  The epileptogenicity of neurolept anaesthesia in patients during and after neuroradiological examinations with metrizamide.

Authors:  A Rudehill; E Gordon; A Grepe; L Widén
Journal:  Acta Anaesthesiol Scand       Date:  1983-08       Impact factor: 2.105

Review 9.  Systemic reactions to intravascular contrast media. A guide for the anesthesiologist.

Authors:  M Goldberg
Journal:  Anesthesiology       Date:  1984-01       Impact factor: 7.892

10.  Iohexol compared to metrizamide in cervical and thoracic myelography. A randomized double blind parallel study.

Authors:  P Nakstad; A Helgetveit; O Aaserud; T Ganes; R Nyberg-Hansen
Journal:  Neuroradiology       Date:  1984       Impact factor: 2.804

  10 in total
  2 in total

1.  Intra-arterial iodinated radiographic contrast material injection administration in a rat middle cerebral artery occlusion and reperfusion model: possible effects on intracerebral hemorrhage.

Authors:  Yuko Kurosawa; Aigang Lu; Pooja Khatri; Janice A Carrozzella; Joseph F Clark; Jane Khoury; Thomas A Tomsick
Journal:  Stroke       Date:  2010-04-01       Impact factor: 7.914

2.  High-dose contrast-enhanced computed tomography (CECT) with iopamidol in the detection of cerebral metastases. Tolerance of the contrast agent.

Authors:  M Leonardi; A Lavaroni; E Biasizzo; G Fabris; T Penco; F Zappoli
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.